{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/greater-trochanteric-pain-syndrome-trochanteric-bursitis/how-this-topic-was-developed/stakeholder-engagement/","result":{"pageContext":{"chapter":{"id":"bef561b0-fdbb-5484-aaa5-79494ba00a8b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement","depth":2,"htmlHeader":"<!-- begin field 9cf49d73-84ac-4719-92af-a7f201753b63 --><h2>Stakeholder engagement</h2><!-- end field 9cf49d73-84ac-4719-92af-a7f201753b63 -->","summary":null,"htmlStringContent":"<!-- begin item 59c2c995-e1dd-47be-9b28-a7f20174d91e --><!-- begin field 4e7298ea-0f07-47d7-8560-a7f201753b63 --><h2>Our policy</h2><!-- end field 4e7298ea-0f07-47d7-8560-a7f201753b63 --><!-- begin field 9521d1c1-9681-4355-a357-a7f201753b63 --><p>The external review process is an essential part of CKS topic development. Consultation with a wide range of stakeholders provides quality assurance of the topic in terms of:</p><ul><li>Clinical accuracy.</li><li>Consistency with other providers of clinical knowledge for primary care.</li><li>Accuracy of implementation of national guidance (in particular NICE guidelines).</li><li>Usability.</li></ul><!-- end field 9521d1c1-9681-4355-a357-a7f201753b63 --><!-- begin field 72a272fe-f1c4-4e79-b8fa-a7f201753b63 --><h2>Principles of the consultation process</h2><!-- end field 72a272fe-f1c4-4e79-b8fa-a7f201753b63 --><!-- begin field 3ba4e76d-19c9-4995-917d-a7f201753b63 --><ul><li>The process is inclusive and any individual may participate.</li><li>To participate, an individual must declare whether they have any competing interests or not. If they do not declare whether or not they have competing interests, their comments will not be considered.</li><li>Comments received after the deadline will be considered, but they may not be acted upon before the clinical topic is issued onto the website.</li><li>Comments are accepted in any format that is convenient to the reviewer, although an electronic format is encouraged.</li><li>External reviewers are not paid for commenting on the draft topics.</li><li>Discussion with an individual or an organization about the CKS response to their comments is only undertaken in exceptional circumstances (at the discretion of the Clinical Editor or Editorial Steering Group).</li><li>All reviewers are thanked and offered a letter acknowledging their contribution for the purposes of appraisal/revalidation.</li><li>All reviewers are invited to be acknowledged on the website. All reviewers are given the opportunity to feedback about the external review process, enabling improvements to be made where appropriate.</li></ul><!-- end field 3ba4e76d-19c9-4995-917d-a7f201753b63 --><!-- begin field dca4e3fe-9bee-43b1-b5ca-a7f201753b63 --><h2>Stakeholders</h2><!-- end field dca4e3fe-9bee-43b1-b5ca-a7f201753b63 --><!-- begin field a40b320f-cc6a-4b25-b87a-a7f201753b63 --><ul><li>Key stakeholders identified by the CKS team are invited to comment on draft CKS topics. Individuals and organizations can also register an interest to feedback on a specific topic, or topics in a particular clinical area, through the <a href=\"http://cks.clarity.co.uk/get-involved/\" data-hyperlink-id=\"53cba7e5-bcc2-4933-a687-a991015683d7\">Getting involved</a> section of the <a href=\"https://clarity.co.uk/\" data-hyperlink-id=\"fdfb51db-d261-4652-a673-a991015684b9\">Clarity Informatics</a> website.</li><li>Stakeholders identified from the following groups are invited to review draft topics:<ul><li>Experts in the topic area.</li><li>Professional organizations and societies (for example, Royal Colleges).</li><li>Patient organizations, Clarity has established close links with groups such as Age UK and the Alzheimer’s Society specifically for their input into new topic development, review of current topic content and advice on relevant areas of expert knowledge.</li><li>Guideline development groups where the topic is an implementation of a guideline.</li><li>The British National Formulary team.</li><li>The editorial team that develop MeReC Publications.</li></ul></li><li>Reviewers are provided with clear instructions about what to review, what comments are particularly helpful, how to submit comments, and declaring interests.</li></ul><!-- end field a40b320f-cc6a-4b25-b87a-a7f201753b63 --><!-- begin field 84141c74-e82f-49e5-ad4a-a7f201753b63 --><h2>Patient engagement</h2><!-- end field 84141c74-e82f-49e5-ad4a-a7f201753b63 --><!-- begin field 068dbf35-46d7-4405-8c45-a7f201753b63 --><p>Clarity Informatics has enlisted the support and involvement of patients and lay persons at all stages in the process of creating the content which include:</p><ul><li>Topic selection</li><li>Scoping of topic</li><li>Selection of clinical scenarios</li><li>First draft internal review</li><li>Second draft internal review</li><li>External review</li><li>Final draft and pre-publication</li></ul><p>Our lay and patient involvement includes membership on the editorial steering group, contacting expert patient groups, organizations and individuals.</p><!-- end field 068dbf35-46d7-4405-8c45-a7f201753b63 --><!-- end item 59c2c995-e1dd-47be-9b28-a7f20174d91e -->","topic":{"id":"f5b64608-cf1c-5e43-8737-57e5c43550a6","topicId":"312878ed-d57e-45ae-9e8d-d81933eef21e","topicName":"Greater trochanteric pain syndrome (trochanteric bursitis)","slug":"greater-trochanteric-pain-syndrome-trochanteric-bursitis","lastRevised":"Last revised in August 2016","chapters":[{"id":"93366306-a91c-5e3b-b2c9-c2ba25bd6c6a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0793a5da-3642-58ce-b602-5e6bcd3d1fc0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"db6919a8-9f39-59b7-90bb-8005f7a8f6a9","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"71e3ba74-5e5b-53af-90a2-64747eb09aea","slug":"changes","fullItemName":"Changes"},{"id":"3d3b603c-0380-5f28-9b95-f13574e76f3a","slug":"update","fullItemName":"Update"}]},{"id":"54aea975-a119-5ee3-8b76-439e722659bf","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"33b0bc5a-2a02-5111-8bac-32cb98e0edd9","slug":"goals","fullItemName":"Goals"},{"id":"e8e59fdd-81cd-58e5-ab1b-d12935423e34","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"151aa29e-1733-53b2-b17c-9218455ce895","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ed20ef05-d37e-502a-8689-79993edfc5ed","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d058cfb7-eb0b-5f86-9651-7d1b619f95bc","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5d1fb9c1-8d6b-53fa-acc8-217e078359d5","slug":"nice-quality-standards","fullItemName":"NICE Quality Standards"}]},{"id":"2ee41038-4731-5ebb-a207-ae122da3c607","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4291641d-ace5-5da8-80b1-e7fe14ce0986","slug":"definition","fullItemName":"Definition"},{"id":"488caa86-0f5d-5f04-b74d-c7cad8737ff0","slug":"causes","fullItemName":"Causes"},{"id":"bec80eec-9d11-581d-891f-cdc61d00fb8d","slug":"associated-conditions","fullItemName":"Associated conditions"},{"id":"380159dc-b5be-5c9f-bde7-8f30e44c4b7a","slug":"incidence-prevalence","fullItemName":"Incidence and prevalence"},{"id":"3413f952-6ab3-5674-8c56-90970afff5fc","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ef1e13b6-e28a-57a6-a8c1-d541a9e19bed","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ac73348d-f809-5f32-93ae-b2e83e8e3227","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"6d0d8f17-9ae7-5e34-a757-adf160bdae32","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3e1b1d0c-6cf5-5409-857b-0fee878194ae","fullItemName":"Management","slug":"management","subChapters":[{"id":"78a5772c-d4a0-54ad-8196-480e313e048b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"c7b85e3c-6820-5f01-a7c6-5414b0f1fa6e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"36478d75-f4ee-534d-ac6f-840edc462d38","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0d26623f-bf65-5e3b-a14d-7ff84a3d519e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"bef561b0-fdbb-5484-aaa5-79494ba00a8b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3c17a9f4-ea55-5f3a-b485-51b0c6224eb9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2d7f998d-de79-5c94-9767-c1b1e084b390","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6315d5e8-01bb-5a01-88df-3d121d066f41","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"937a0c97-1412-5dee-bf5d-83a1498684c9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"36478d75-f4ee-534d-ac6f-840edc462d38","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}